🔴 Trulieve Cannabis is trading 4.03% down amid broad market weakness; catalyst unclear

Trulieve Cannabis is trading 4.03% down at $10.48, with no clear company-specific catalyst identified for October 23, 2026.

• Cantor Fitzgerald reiterated its Overweight rating and $15 price target, which does not explain the decline.
• Geopolitical tensions and higher oil prices accompany broad risk-off sentiment; major indexes are lower, including the Dow at -1.38%.
• Supplied sector context points to profit-taking in consumer staples; market and sector factors may provide context, but the direct cause remains uncertain.